Browse > Article

Methamphetamine and MDMA (3,4-methylenedioxymethamphetamine) Induce Apoptosis in Both Human Serotonergic and Dopaminergic Cell Lines  

Kim, Kyu Bong (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA)
Suh, Soo Kyung (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA)
Lee, Bo Kyung (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA)
Kim, Byung Kyu (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA)
Kim, Jae Hee (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA)
Han, Eui Sik (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA)
Park, Chang Won (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA)
Kim, Jong Won (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA)
Kim, Kwang Jin (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA)
Lee, Sun Hee (Division of Safety Evaluation, National Institute of Toxicological Research, KFDA)
Publication Information
Biomolecules & Therapeutics / v.11, no.4, 2003 , pp. 214-223 More about this Journal
Abstract
Methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA) have become popular recreational drugs of abuse in many countries. Although the neurotoxic damage caused by METH and MDMA is characterized by degeneration of the dopaminergic and serotonergic systems in brain, the molecular and cellular mechanisms remain to be clarified. Therefore, the purposes of this study were to confirm the capability of METH and MDMA to induce apoptosis and to clarify the action of its molecular mechanism by using serotonergic JAR cells and dopaminergic SK-N-SH cells. METH and MDMA were dose-dependently cytotoxic to human serotonergic JAR cells and dopaminergic SK-N-SH cells. The morphological change of apoptosis was found in Giemsa staining and TUNEL and further verified in DNA fragmentation analysis. Immunoblotting analysis revealed proteolytic cleavage of caspase-3 and -9 and change of bcl-2 and bax proteins. These results suggest that METH and MDMA may induce caspase-dependent apoptosis via the mitochondrial cell death pathway and METH and MDMA-induced neurotoxicity may happen to broadly and independently of both dopaminergic and serotonergic systems.
Keywords
METH; MDMA; neurotoxicity; apoptosis; dopaminergic and serotonergic cells;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Tmam, S.Z., Itzhak, Y, Cadet, J.L., Islam, F, Slikker, W. Jr., and Ali, S.F. (2001). Methaniphetamine-induced alteration in stii-atal p53 and bc1-2 expression in mice. Mol. Brain Res. 90. 174-178   DOI   ScienceOn
2 Insel, T.R., Battaglia, G., Johannessen, J.N., Marra, S., and Souza, EBD. (1989). 3,4-Methy1enedioxymethamphetmine ('Ecstacy') selectively destroys brain serotonin tenninaIs in Rhesus Mon keys. J. Pharmacol. Exp. Ther. 249, 713-720
3 O'Shea, E., Granados, R., Esteban, B., Colado, M.L, and Green, A.R. (1998). The relationship between the degree of neurode-generation of rat brain 5-HT nerve terminals and the dose and frequency of adimnistation of MDMA (ecstacy). Neurophar-macol. 37, 919-926   DOI   ScienceOn
4 Ricaurte, G., Bryan, G., Strauss, L., Seidcn, L., and Schuster. C. (1985). Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science 229, 986-988   DOI
5 Baldwin, H.A., Colado, M.I., Murray, T.K., De Souza, R.J. and Green, W.J. (1993). Striatal dopamine release in vivo follow-ing neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine. Br. J. Pharmacol. 108, 590-596   DOI   ScienceOn
6 Berger, U.V., Gu, X.F. and Aznitia, E.C. (1992). The substituted amphetamine 3,4-methy1enedioxymethamphetamine, mctham-phetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptanune release via a common mechanism blocked by fluoxetin and cocaine. Eur. J. Pharmacol. 215, 153-160   DOI   ScienceOn
7 Giovanni, A., Liang, L.P., Hastings, T.G., and Zigmond, M.J. (1995). Estimating hydroxy radical content in rat brain using systemic and intraventhcular salicylate: impact of metham- phetamine. J. Neurochem. 64, 1819-1825   DOI   ScienceOn
8 Davidson, C., Gow, A.J., Lee, T.H. and Ellinwood, E.H. (2001). Methamphetamine ncurotoxicily: necrotic and apoptotic mech-anisms and relevance to human abuse and treatrment. Brain Res. Reviews 36, 1-22   DOI   ScienceOn
9 De Vito M.J. and Wagner, G.C. (1989). Methamphetaimne-induced neuronal damage: a possible role for free radicals. Neurophar-macology 28, 1145-1150   DOI
10 Fleckcnstein, A.E., Gibb, J.W. and Hanson, G.R. (2000). Differ-ential effects of stimulants on monoaminergic transporters: pharmacological consequences and implicadons for neurotox-icity. Eur. J. Pharmacol. 406, 1-13   DOI   ScienceOn
11 Hirata, H.H., Ladenheim, B., Carlson, E., Epstein, C., and Cadet, J.L. (1996). Automdiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuadon in CuZn-superoxide dismutase transgenic mice. Brain Res. 714, 95-103   DOI   ScienceOn
12 Woolverton, W.L., Ricaurte, G.A., Forno, L.S., and Seiden, L.S. (1989). Long term effects of chronic methamphetaimne admin-istration in rhesus monkeys. Brain Res. 11, 73-78
13 Jayanthi, S., Deng, X., Bordelon, M., McCoy, M.T, and Cadet, J.L. (2001). Methamphetamine causes differential regulation of pro-death and anti-death Bc1-2 genes in the mouse neocortex. FASEB J. 15, 1745-1752   DOI   ScienceOn
14 Johnston, L.D., OMalley, P.M., Bachman, J.G. (2000). Monitor-ing the future national survey results on adolescent drug use:overview of the key findings, 1999 (NIH publication number00-4690)
15 Lemaster, J.J., Qian, T., Bradham, D.A., Brenner, W.E., Cascio, L.C., Trost, Y., Nishmura, Y, Nieminen, A.L., and Herman, B. (1999). Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell dcath. J. Bioenerg. Biomembr. 31. 305-319   DOI   ScienceOn
16 Keenan, E., Gervin, M., Dorman, A., and OConnor, J.J. (1993). Psychosis and recreational use of MDMA ('Ecstacy'). Irish J. Psychol. Med. 10, 162-163
17 Kleven, M.S. and Seiden, L.S. (1992). Methamphetamine-induced neurotoxicity: structure activity relationships. Ann. NY. Acad. Sci. 654, 292-301   DOI   ScienceOn
18 Kuczenski, R., Segal, D.S., Cho, A.K. and Melega, W. (1995). Hippocampus norepinephrine, caudate dopamine and seroto nine, and behavioral responses Lo the stereoisomers of amphet-aminne and methamphetamine. J. Neurosci. 15, 1308-1317
19 Leshner, A.I. (2001). Using science to counter the spread of Ecstacy abuse. NIDA Notes. 16, 3-4
20 Lieberman, J.A., Kinon, B.J., and Loebel, A.D. (1990). Dopamin-ergic mechanisms in idiopathic and drug-induced psychoses. Schizophr. Bull. 16, 97-110   DOI   ScienceOn
21 Seiden, L.S. and Vosmer, G. (1984). Formation of 6-hydroxy-dopamine in caudate nucleus of the rat brain after a single large dose of methamphetamine. Pharmacol. Biochem. Beha. 21, 29-31   DOI   ScienceOn
22 Thiriet, N., Jayanthi, S., McCoy, M., Ladenheim, B., and Cadet, J.L. (2001). Methamphetamine increases expression of the apoptotic c-myc and L-myc genes in the mouse brain. Mol.Brain Res. 90, 202-204   DOI   ScienceOn
23 Simantov, R. and Tauber, M. (1997). The abuse drug MDMA (Ecstacy) induces programmed death of human serotonergic cells. FASEB J. 11, 141-146
24 Sprague, J.E., Everman, S.L., and Nichols, D.E. (1998). An inte-gratcd hypothesis for the serotonergic axonal loss induced by 3,4-methy1enedioxymethamphetmine. Neurotoxicol. 19, 427-441
25 Stone, D.M., Johnson, M., Hanson, G.R., and Gibb, J.W. (1988). Rolc of endogenous dopamine in the central serotonergic defi-cits induced by 3,4-methy1enedioxy- methamphetmine. J. Pharmacol. Exp. Ther. 247, 79-87
26 Volkow, N.D., Chang, L., Wang, G.J., Fowler, J.S., Franceschi D., Sedler, M., Gatley, S.J., Miller, E., Hitzemann, R., Ding, Y.S., and Logan, J. (2001). Loss of dopamine transporters inmethamphetamine abusers recovers with protracted absti-nence. J. Neurosci. 21, 9414-9418
27 Wagner, G.C., Ricaurte, G.A., Seiden, L.S., Schuster, C.R., Miller, R.J., and Westley, J. (1980). Long-lasting depletions of stnatal dopamine and loss of dopamine uptake sites following rcpeated admimstralion of methamphetamine. Brain Res. 181.151-160   DOI   ScienceOn